We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing program.
- Authors
Morton, Christopher L; Maris, John M; Keir, Stephen T; Gorlick, Richard; Kolb, E Anders; Billups, Catherine A; Wu, Jianrong; Smith, Malcolm A; Houghton, Peter J
- Abstract
Cediranib (AZD2171) is a potent small molecule inhibitor of vascular endothelial growth factor (VEGF) receptors. Cediranib has demonstrated single agent activity in several adult cancers and is being studied in combination with standard cytotoxic agents in multiple disease settings.
- Publication
Pediatric blood & cancer, 2012, Vol 58, Issue 4, p566
- ISSN
1545-5017
- Publication type
Journal Article
- DOI
10.1002/pbc.23159